Accelerated development of 13-step intermediate to reduce time to market

Global top 15 US Pharma Co.

Theme	Accelerated development of 13-step intermediate to reduce time to market
Partner	Global top 15 US Pharma Co.
Context	Pharma Co. looking to: -Move away from EU suppliers (due to high cost) -Partner with non-China suppliers to develop a complex non-pyridine based active Prior relationship of 8+ yrs.
What Ingrevia did	Synthesized complex intermediate involving a 13+ Step chemistry Re-engineered route of synthesis to ensure even effluents are non-hazardous Collaborated with Group Co. to supply active, synthesized from the intermediate
Outcome	Synthesis to active production in 5 months (faster than in-house route) Outsourced supply chain Comprehensive solution provided – Synthesis to production

Let’s build what’s next

Start a conversation with Jubilant Ingrevia and engage the teams delivering at scale across our businesses. Share your interest, and we’ll connect you with the right leaders to take it forward.